Vaccine (Peptide vaccine) · Immune activation, directed at Tyrosinase (TYR), MAGE-C2 and NY-ESO-1 (CTAG1B)
Phase 1/2Most advanced trial (none active)
1Registered trials
What is HLA-A2 peptides?
HLA-A2 peptides are a set of synthetic peptide vaccine components, each matched to HLA-A2 and derived from a tumor antigen such as tyrosinase, NY-ESO-1 and several MAGE family proteins. They are studied for immune activation against melanoma.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.